New

Benign Prostatic Hyperplasic Devices Market

2021

Benign Prostatic Hyperplasic Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Procedure Type (Transurethral Microwave Therapy, Transurethral Resection of the Prostate, Transurethral Needle Ablation of the Prostate, Prostatic Stenting, Laser Surgery, Others); End User (Hospitals and Clinics, Ambulatory Surgical Centers, Others) and Geography

| Report Code: TIPRE00025704 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming

Market Insights

Benign Prostatic Hyperplasic Devices Market 2028 By Procedure Type, End User and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

The enlargement of the prostate gland is known as benign prostatic hyperplasia (BPH). The enlargement of this gland is generally seen in the baby boomers. This may cause symptom such as uncomfortable urine and can also cause bladder or kidney problems. The risk factors for the enlarged prostate glands are aging, family history, diabetes, heart disease and lifestyle.

MARKET SCOPE

The "Global Benign Prostatic Hyperplasic Devices Market Analysis to 2028" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of the benign prostatic hyperplasic devices market with detailed market segmentation by procedure type, end user, and geography. The report provides key statistics on the market status of the leading benign prostatic hyperplasic devices market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •   Based on procedure type, the global benign prostatic hyperplasic devices market is segmented into Transurethral Microwave Therapy, Transurethral Resection of the Prostate, Transurethral Needle Ablation of the Prostate, Prostatic Stenting, Laser Surgery and Others.
  •   On the basis of end user, the market is segmented into Hospitals & Clinics, Ambulatory Surgical Centers and Others.

MARKET DYNAMICS
Drivers:

  •   Increase in the geriatric population
  •   Rising awareness for prostate cancer and other urological disorders

Restraints:

  •   Limitations associated with BPS devices

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The benign prostatic hyperplasic devices market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the benign prostatic hyperplasic devices market in these regions.

IMPACT OF COVID-19 ON BENIGN PROSTATIC HYPERPLASIC DEVICES MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. COVID-19 severely impacted the benign prostatic hyperplasic devices market as BPS was positioned to be one of the lowest priorities of non-oncological procedures.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the benign prostatic hyperplasic devices market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from benign prostatic hyperplasic devices market are anticipated to lucrative growth opportunities in the future with the rising demand for benign prostatic hyperplasic devices in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the benign prostatic hyperplasic devices market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   Astellas Pharma.
  •   Allergan plc.
  •   Abbott Laboratories
  •   Boehringer Ingelheim Pharma GmbH and Co
  •   Merck & Co., Inc.
  •   GlaxoSmithKline plc
  •   Nymox Pharmaceutical
  •   Ipsen S. A
  •   Eli Lilly and Company
  •   Sanofi


The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Benign Prostatic Hyperplasic Devices Market - By Procedure Type
1.3.2 Benign Prostatic Hyperplasic Devices Market - By End User
1.3.3 Benign Prostatic Hyperplasic Devices Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BENIGN PROSTATIC HYPERPLASIC DEVICES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BENIGN PROSTATIC HYPERPLASIC DEVICES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. BENIGN PROSTATIC HYPERPLASIC DEVICES MARKET - GLOBAL MARKET ANALYSIS
6.1. BENIGN PROSTATIC HYPERPLASIC DEVICES - GLOBAL MARKET OVERVIEW
6.2. BENIGN PROSTATIC HYPERPLASIC DEVICES - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. BENIGN PROSTATIC HYPERPLASIC DEVICES MARKET - REVENUE AND FORECASTS TO 2028 - PROCEDURE TYPE
7.1. OVERVIEW
7.2. PROCEDURE TYPE MARKET FORECASTS AND ANALYSIS
7.3. TRANSURETHRAL MICROWAVE THERAPY
7.3.1. Overview
7.3.2. Transurethral Microwave Therapy Market Forecast and Analysis
7.4. TRANSURETHRAL RESECTION OF THE PROSTATE
7.4.1. Overview
7.4.2. Transurethral Resection of the Prostate Market Forecast and Analysis
7.5. TRANSURETHRAL NEEDLE ABLATION OF THE PROSTATE
7.5.1. Overview
7.5.2. Transurethral Needle Ablation of the Prostate Market Forecast and Analysis
7.6. PROSTATIC STENTING
7.6.1. Overview
7.6.2. Prostatic Stenting Market Forecast and Analysis
7.7. LASER SURGERY
7.7.1. Overview
7.7.2. Laser Surgery Market Forecast and Analysis
7.8. OTHERS
7.8.1. Overview
7.8.2. Others Market Forecast and Analysis
8. BENIGN PROSTATIC HYPERPLASIC DEVICES MARKET - REVENUE AND FORECASTS TO 2028 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS AND CLINICS
8.3.1. Overview
8.3.2. Hospitals and Clinics Market Forecast and Analysis
8.4. AMBULATORY SURGICAL CENTERS
8.4.1. Overview
8.4.2. Ambulatory Surgical Centers Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. BENIGN PROSTATIC HYPERPLASIC DEVICES MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Benign Prostatic Hyperplasic Devices Market Overview
9.1.2 North America Benign Prostatic Hyperplasic Devices Market Forecasts and Analysis
9.1.3 North America Benign Prostatic Hyperplasic Devices Market Forecasts and Analysis - By Procedure Type
9.1.4 North America Benign Prostatic Hyperplasic Devices Market Forecasts and Analysis - By End User
9.1.5 North America Benign Prostatic Hyperplasic Devices Market Forecasts and Analysis - By Countries
9.1.5.1 United States Benign Prostatic Hyperplasic Devices Market
9.1.5.1.1 United States Benign Prostatic Hyperplasic Devices Market by Procedure Type
9.1.5.1.2 United States Benign Prostatic Hyperplasic Devices Market by End User
9.1.5.2 Canada Benign Prostatic Hyperplasic Devices Market
9.1.5.2.1 Canada Benign Prostatic Hyperplasic Devices Market by Procedure Type
9.1.5.2.2 Canada Benign Prostatic Hyperplasic Devices Market by End User
9.1.5.3 Mexico Benign Prostatic Hyperplasic Devices Market
9.1.5.3.1 Mexico Benign Prostatic Hyperplasic Devices Market by Procedure Type
9.1.5.3.2 Mexico Benign Prostatic Hyperplasic Devices Market by End User
9.2. EUROPE
9.2.1 Europe Benign Prostatic Hyperplasic Devices Market Overview
9.2.2 Europe Benign Prostatic Hyperplasic Devices Market Forecasts and Analysis
9.2.3 Europe Benign Prostatic Hyperplasic Devices Market Forecasts and Analysis - By Procedure Type
9.2.4 Europe Benign Prostatic Hyperplasic Devices Market Forecasts and Analysis - By End User
9.2.5 Europe Benign Prostatic Hyperplasic Devices Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Benign Prostatic Hyperplasic Devices Market
9.2.5.1.1 Germany Benign Prostatic Hyperplasic Devices Market by Procedure Type
9.2.5.1.2 Germany Benign Prostatic Hyperplasic Devices Market by End User
9.2.5.2 France Benign Prostatic Hyperplasic Devices Market
9.2.5.2.1 France Benign Prostatic Hyperplasic Devices Market by Procedure Type
9.2.5.2.2 France Benign Prostatic Hyperplasic Devices Market by End User
9.2.5.3 Italy Benign Prostatic Hyperplasic Devices Market
9.2.5.3.1 Italy Benign Prostatic Hyperplasic Devices Market by Procedure Type
9.2.5.3.2 Italy Benign Prostatic Hyperplasic Devices Market by End User
9.2.5.4 Spain Benign Prostatic Hyperplasic Devices Market
9.2.5.4.1 Spain Benign Prostatic Hyperplasic Devices Market by Procedure Type
9.2.5.4.2 Spain Benign Prostatic Hyperplasic Devices Market by End User
9.2.5.5 United Kingdom Benign Prostatic Hyperplasic Devices Market
9.2.5.5.1 United Kingdom Benign Prostatic Hyperplasic Devices Market by Procedure Type
9.2.5.5.2 United Kingdom Benign Prostatic Hyperplasic Devices Market by End User
9.2.5.6 Rest of Europe Benign Prostatic Hyperplasic Devices Market
9.2.5.6.1 Rest of Europe Benign Prostatic Hyperplasic Devices Market by Procedure Type
9.2.5.6.2 Rest of Europe Benign Prostatic Hyperplasic Devices Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Benign Prostatic Hyperplasic Devices Market Overview
9.3.2 Asia-Pacific Benign Prostatic Hyperplasic Devices Market Forecasts and Analysis
9.3.3 Asia-Pacific Benign Prostatic Hyperplasic Devices Market Forecasts and Analysis - By Procedure Type
9.3.4 Asia-Pacific Benign Prostatic Hyperplasic Devices Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Benign Prostatic Hyperplasic Devices Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Benign Prostatic Hyperplasic Devices Market
9.3.5.1.1 Australia Benign Prostatic Hyperplasic Devices Market by Procedure Type
9.3.5.1.2 Australia Benign Prostatic Hyperplasic Devices Market by End User
9.3.5.2 China Benign Prostatic Hyperplasic Devices Market
9.3.5.2.1 China Benign Prostatic Hyperplasic Devices Market by Procedure Type
9.3.5.2.2 China Benign Prostatic Hyperplasic Devices Market by End User
9.3.5.3 India Benign Prostatic Hyperplasic Devices Market
9.3.5.3.1 India Benign Prostatic Hyperplasic Devices Market by Procedure Type
9.3.5.3.2 India Benign Prostatic Hyperplasic Devices Market by End User
9.3.5.4 Japan Benign Prostatic Hyperplasic Devices Market
9.3.5.4.1 Japan Benign Prostatic Hyperplasic Devices Market by Procedure Type
9.3.5.4.2 Japan Benign Prostatic Hyperplasic Devices Market by End User
9.3.5.5 South Korea Benign Prostatic Hyperplasic Devices Market
9.3.5.5.1 South Korea Benign Prostatic Hyperplasic Devices Market by Procedure Type
9.3.5.5.2 South Korea Benign Prostatic Hyperplasic Devices Market by End User
9.3.5.6 Rest of Asia-Pacific Benign Prostatic Hyperplasic Devices Market
9.3.5.6.1 Rest of Asia-Pacific Benign Prostatic Hyperplasic Devices Market by Procedure Type
9.3.5.6.2 Rest of Asia-Pacific Benign Prostatic Hyperplasic Devices Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Benign Prostatic Hyperplasic Devices Market Overview
9.4.2 Middle East and Africa Benign Prostatic Hyperplasic Devices Market Forecasts and Analysis
9.4.3 Middle East and Africa Benign Prostatic Hyperplasic Devices Market Forecasts and Analysis - By Procedure Type
9.4.4 Middle East and Africa Benign Prostatic Hyperplasic Devices Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Benign Prostatic Hyperplasic Devices Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Benign Prostatic Hyperplasic Devices Market
9.4.5.1.1 South Africa Benign Prostatic Hyperplasic Devices Market by Procedure Type
9.4.5.1.2 South Africa Benign Prostatic Hyperplasic Devices Market by End User
9.4.5.2 Saudi Arabia Benign Prostatic Hyperplasic Devices Market
9.4.5.2.1 Saudi Arabia Benign Prostatic Hyperplasic Devices Market by Procedure Type
9.4.5.2.2 Saudi Arabia Benign Prostatic Hyperplasic Devices Market by End User
9.4.5.3 U.A.E Benign Prostatic Hyperplasic Devices Market
9.4.5.3.1 U.A.E Benign Prostatic Hyperplasic Devices Market by Procedure Type
9.4.5.3.2 U.A.E Benign Prostatic Hyperplasic Devices Market by End User
9.4.5.4 Rest of Middle East and Africa Benign Prostatic Hyperplasic Devices Market
9.4.5.4.1 Rest of Middle East and Africa Benign Prostatic Hyperplasic Devices Market by Procedure Type
9.4.5.4.2 Rest of Middle East and Africa Benign Prostatic Hyperplasic Devices Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Benign Prostatic Hyperplasic Devices Market Overview
9.5.2 South and Central America Benign Prostatic Hyperplasic Devices Market Forecasts and Analysis
9.5.3 South and Central America Benign Prostatic Hyperplasic Devices Market Forecasts and Analysis - By Procedure Type
9.5.4 South and Central America Benign Prostatic Hyperplasic Devices Market Forecasts and Analysis - By End User
9.5.5 South and Central America Benign Prostatic Hyperplasic Devices Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Benign Prostatic Hyperplasic Devices Market
9.5.5.1.1 Brazil Benign Prostatic Hyperplasic Devices Market by Procedure Type
9.5.5.1.2 Brazil Benign Prostatic Hyperplasic Devices Market by End User
9.5.5.2 Argentina Benign Prostatic Hyperplasic Devices Market
9.5.5.2.1 Argentina Benign Prostatic Hyperplasic Devices Market by Procedure Type
9.5.5.2.2 Argentina Benign Prostatic Hyperplasic Devices Market by End User
9.5.5.3 Rest of South and Central America Benign Prostatic Hyperplasic Devices Market
9.5.5.3.1 Rest of South and Central America Benign Prostatic Hyperplasic Devices Market by Procedure Type
9.5.5.3.2 Rest of South and Central America Benign Prostatic Hyperplasic Devices Market by End User
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL BENIGN PROSTATIC HYPERPLASIC DEVICES MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. BENIGN PROSTATIC HYPERPLASIC DEVICES MARKET, KEY COMPANY PROFILES
12.1. ASTELLAS PHARMA.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ALLERGAN PLC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ABBOTT LABORATORIES
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BOEHRINGER INGELHEIM PHARMA GMBH AND CO
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. MERCK AND CO., INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. GLAXOSMITHKLINE PLC
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. NYMOX PHARMACEUTICAL
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. IPSEN S. A
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. ELI LILLY AND COMPANY
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. SANOFI
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS

The List of Companies

1. Astellas Pharma.
2. Allergan plc.
3. Abbott Laboratories
4. Boehringer Ingelheim Pharma GmbH and Co
5. Merck & Co., Inc.
6. GlaxoSmithKline plc
7. Nymox Pharmaceutical
8. Ipsen S. A
9. Eli Lilly and Company
10. Sanofi
11. Olympus Medical
12. Butterfly Medical
13. SRS Medical
14. Teleflex Medical
15. Urotronic
16. ProArc Medical
17. Medion Biodesign
18. Zenflow
TIPRE00025704
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.